Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y2SW
|
|||
| Drug Name |
Ixazomib
|
|||
| Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90] | Approved | [1] | |
| Company |
Takeda Oncology Deerfield, IL
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C14H19BCl2N2O4
|
|||
| Canonical SMILES |
B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O
|
|||
| InChI |
1S/C14H19BCl2N2O4/c1-8(2)5-12(15(22)23)19-13(20)7-18-14(21)10-6-9(16)3-4-11(10)17/h3-4,6,8,12,22-23H,5,7H2,1-2H3,(H,18,21)(H,19,20)/t12-/m0/s1
|
|||
| InChIKey |
MXAYKZJJDUDWDS-LBPRGKRZSA-N
|
|||
| CAS Number |
CAS 1072833-77-2
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:90942
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.